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Table 1. Outcome of all pregnancies according to treatment 
with ivermectin 
Mother Mother not 
Absence of any adverse effect of 
inadvertent ivermectin treatment 
dur in g pregnancy 
Jean-Phitippe Chippaux, Nathalie Gardon-Wendel, 
Jacques Gardon and Jean-Christophe Ernouid Centre 
Pasteur du Cameroun, B.P. 1274, Yaoundé, Cameroun 
and Centre ORSTOM de Yaoundé 
. t  
Although ivermectin is safe and well tolerated when 
distributed through mass treatment, pregnancy remains 
the major contraindication. PACQUÉ et al. (1990) con- 
sidered that about half of the women in the first trimester 
of pregnancy might be treated inadvertently during com- 
munity-based distribution of ivermectin, and stated that 
rates of miscarriage, stillbirth or major congenital malfor- 
mation were not significantly different between treated 
and untreated women, 
During a mass treatment campaign for onchocerciasis 
in the Vina valley, North Cameroon, 2710 women from 
15 to 45 vears old received ivermectin. Of 1495 women 
treated tre at ed 
No. of subjects 110 401 
Early abortion (<4, months) 4 (3.6%) 9 (2.2%) 
Late abnormal events (abortion, 
miscarriage, stillbirth) 17 (15.5%) 44 (11%) 
Children not seen , 8 (7.3%) 45" (11.2%) 
Normal children 82" (74.5%) 304a (75.8%) 
Children with malformationsb O 2 (0.5%) 
"Including 1 or 2 sets of twins. 
bFor statistical calculation, these children were included with 
the 'late abnormal events: group. 
# .  
the first trimester of pregnancy. Again, the prevalence of 
abnormal obstetric events did not differ significantlv be- 
tween the 2 groups (x2=2.43,, 
P>0.48; Table 2). 
This study confirmed the obs 
al. (19901, that hermectin did not induce ànv maior we- 
cific congenital malformation, nor did it increase ihe iate 
of abortion and miscarriage, even if treatment was given 
during the very early stages of 
Table 2. Outcome of first trimeste 
treatment with ivermectin 
4 Mother Mother not 
treated treated 
questioneh in 1990, 225 were pregnant and were not 
treated. In 1991, 176 of 1215 women were pregnant and 
did cot receive ivermectin. Every 3 months following the 
drug distribution, each woman was questioned about her No. of subjects 97 1 142 
pregnancy by a medical doctor. All abnormal events were Early abortion (<4 months) 4 (4.1%) 8 (5.6%) 
10 (10.3%) 23 (16.2%) recorded and checked at every subsequent survey. The date of delivery permitted determination a posteriori of 75" (77.3%) 9gb (69.7%) 
the duration of pregnancy when the ivermectin was dis- Children not Seen 8 (8.2%) 12 (8.5%) tribilted. If delivery occurred within 40 weeks of iver- 
mectin distribution, treatment was considered as having 
been given during pregnancy. Pathological events such bone died after birth* 
as abortion; miscarriage, or stillbirth were recorded. 
surveys were examined by a 
Or abno'- 
Late 
~~$[~;~$l lb i r th)  
"Four children died after m " l  birth. 
risk of compfications is greatest. considering the benefits 
of ivermectin treatment for people heavily infected with 
Onchocerca volvulus, and the hypothetical nature of the 
women were sufficiently documented to be included in scale distribution of ivermech ,be encour- 
raged. The precaution of avoiding its administration to the study. 
Among the 2179 treated women, 110 were subsequently 
found to have been pregnant when they received her- Acknowledgement 
mectin inadvertently. The prevalence of abnormal obste- This work received financial support from the UNDPWorld 
tric events occurring in treated women was not signifi- BanWHO Special Programme for Research and Training in 
cantly different from that in untreated women (x2=3-08, Tropical Diseases (ID no. 870336). 
3 degrees of freedom, P>0.37; Table 1). Most of the 
women reporting their pregnancy were in a more ad- Reference 
vanced stage of pregnancy, since local popular belief was Pacquk M., Munoz, B., Poetschke, G.9 Foose, J . 9  Greene, B. 
that reporting early pregnancy could result in misfor- M. & Taylor, H. R. (1990). Pregnancy outcome after inad- 
vertent ivermectin treatment during community-based dis- 
tribution. Lancet, 336, 1486-1489. tune. In the untreated group, about 65% of pregnancies were of 4 or more months' duration, while in the treated 
group 85% of pregnancies were under 4 months and 
presented greater risks of abortion from other causes. We 
therefore compared only women, from both groups, in 
born between 
doctor to detect any 
mality in developmental status. The histories of 2580 risks of its administration during pregnancy, the large- 
Ivemectin was not given to 401 pregnant WXIlen- women notifying a pregnancy should be adequate. 
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